Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dominantly inherited, non-coding microsatellite expansion disorders.

Laura P W Ranum1, John W Day

  • 1Institute of Human Genetics, University of Minnesota, MMC 206, 420 Delaware Street SE, Minneapolis, Minnesota 55455, USA. ranum001@umn.edu

Current Opinion in Genetics & Development
|June 22, 2002
PubMed
Summary

Repeat expansions in RNA cause diseases like myotonic dystrophy type 1 and 2. This discovery reveals a new disease category where RNA alterations, not just protein changes, drive illness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PERK deficiency amplifies molecular, structural, and network vulnerability to repetitive mild traumatic brain injury.

Neurobiology of disease·2026
Same author

Cardiac Safety Outcomes in Delandistrogene Moxeparvovec Clinical Trials for Duchenne Muscular Dystrophy with Up to 5 Years of Follow-up.

Cardiology and therapy·2026
Same author

Efficacy and safety of risdiplam in patients with type 1 spinal muscular atrophy: a 3-year open-label extension of the two-part, phase 2 FIREFISH trial.

The Lancet. Child & adolescent health·2026
Same author

Author Correction: High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial.

Nature medicine·2026
Same author

KIF5A downregulation in spinal muscular atrophy links axonal regeneration defects with ALS.

JCI insight·2026
Same author

PERK Deficiency Amplifies Molecular, Structural, and Network Vulnerability to Repetitive Mild Traumatic Brain Injury.

bioRxiv : the preprint server for biology·2026

Area of Science:

  • Genetics
  • Molecular Biology
  • Neurology

Background:

  • Dominantly inherited diseases are often linked to gain-of-function protein mutations.
  • Myotonic dystrophy type 1 (DM1) is caused by a CTG repeat expansion in a kinase gene's 3' untranslated region.
  • Myotonic dystrophy type 2 (DM2) involves a CCTG repeat expansion, presenting similar clinical features to DM1.

Purpose of the Study:

  • To investigate the pathogenic mechanism of repeat expansions in myotonic dystrophies.
  • To establish RNA-level alterations as a disease-causing mechanism.
  • To explore the role of RNA repeat expansions in other neurological disorders.

Main Methods:

  • Analysis of CTG and CCTG repeat expansions in the 3' untranslated regions of specific genes.

Related Experiment Videos

  • Investigation of RNA-level pathogenic mechanisms in DM1 and DM2.
  • Comparative analysis of genetic findings across different repeat expansion disorders.

    • Main Results:

    • Both DM1 and DM2 mutations are pathogenic at the RNA level, not solely due to protein alterations.
    • Repeat expansions in untranslated RNA regions can alter cellular function and cause disease.
    • Similar RNA-level pathogenic mechanisms may be involved in other repeat expansion disorders.

    Conclusions:

    • A new category of disease exists where repeat expansions in RNA directly alter cellular function.
    • Understanding RNA pathogenesis is crucial for diseases like DM1, DM2, and potentially others.
    • This research broadens the scope of genetic disease mechanisms beyond protein mutations.